Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Abbott Laboratories (ABT) had Pre-Tax Income of $2.15B for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$11.14B |
|
$1.78B |
|
$4.85B |
|
$6.29B |
|
$9.09B |
|
$2.05B |
|
$98.00M |
|
|
Pre-Tax Income |
$2.15B |
$2.15B |
|
$1.78B |
|
$1.78B |
|
$1.78B |
|
$1.78B |
|
$2.05B |
|
$2.83B |
|
1.74B |
|
1.75B |
|
$1.02 |
|
$1.01 |
|
| Balance Sheet Financials | |
$24.47B |
|
$11.39B |
|
$59.53B |
|
$84.00B |
|
$13.44B |
|
$12.93B |
|
$19.73B |
|
$33.17B |
|
$50.83B |
|
$20.96B |
|
$50.83B |
|
1.74B |
|
| Cash Flow Statement Financials | |
$3.46B |
|
$-1.05B |
|
$-3.15B |
|
$7.62B |
|
$6.95B |
|
$-665.00M |
|
$431.00M |
|
$-2.06B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.82 |
|
-- |
|
-- |
|
0.20 |
|
0.26 |
|
56.44% |
|
18.42% |
|
18.42% |
|
-- |
|
19.30% |
|
15.97% |
|
$2.48B |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.70 |
|
1.40 |
|
64.39 |
|
3.50% |
|
8.49% |
|
2.12% |
|
2.79% |
|
$29.20 |
|
$1.42 |
|
$1.98 |
|